NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
SSE:600713
Price:
4.9 CNY
0.41%
Market Closed
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
| Current Assets | 26B |
| Cash & Short-Term Investments | 2.2B |
| Receivables | 16.9B |
| Other Current Assets | 7B |
| Non-Current Assets | 2.4B |
| Long-Term Investments | 329m |
| PP&E | 1.5B |
| Intangibles | 291.1m |
| Other Non-Current Assets | 266.2m |
| Current Liabilities | 18.6B |
| Accounts Payable | 6.9B |
| Accrued Liabilities | 378.9m |
| Short-Term Debt | 7B |
| Other Current Liabilities | 4.2B |
| Non-Current Liabilities | 3.4B |
| Long-Term Debt | 2.2B |
| Other Non-Current Liabilities | 1.2B |
Balance Sheet
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 908
|
1 278
|
1 210
|
1 412
|
2 255
|
2 057
|
1 391
|
1 893
|
1 618
|
2 194
|
|
| Cash |
2
|
1
|
1
|
0
|
0
|
0
|
0
|
1 893
|
1 618
|
2 194
|
|
| Cash Equivalents |
1 906
|
1 277
|
1 209
|
1 412
|
2 255
|
2 057
|
1 391
|
0
|
0
|
0
|
|
| Total Receivables |
5 997
|
7 352
|
7 879
|
9 463
|
11 748
|
12 815
|
14 677
|
15 767
|
19 880
|
16 868
|
|
| Accounts Receivables |
5 038
|
6 038
|
6 456
|
7 071
|
8 421
|
7 286
|
9 078
|
10 810
|
14 331
|
11 741
|
|
| Other Receivables |
959
|
1 314
|
1 423
|
2 392
|
3 327
|
5 529
|
5 599
|
4 957
|
5 549
|
5 127
|
|
| Inventory |
1 718
|
2 085
|
2 571
|
2 832
|
2 942
|
3 718
|
4 065
|
4 518
|
5 787
|
5 798
|
|
| Other Current Assets |
483
|
578
|
767
|
1 242
|
755
|
1 158
|
1 031
|
1 281
|
1 977
|
1 153
|
|
| Total Current Assets |
10 105
|
11 293
|
12 427
|
14 949
|
17 701
|
19 748
|
21 165
|
23 458
|
29 261
|
26 013
|
|
| PP&E Net |
621
|
651
|
807
|
889
|
1 094
|
1 178
|
1 219
|
1 529
|
1 521
|
1 511
|
|
| PP&E Gross |
621
|
651
|
807
|
889
|
1 094
|
1 178
|
1 219
|
1 529
|
1 521
|
1 511
|
|
| Accumulated Depreciation |
339
|
389
|
425
|
504
|
563
|
641
|
664
|
827
|
994
|
1 142
|
|
| Intangible Assets |
194
|
180
|
190
|
192
|
192
|
255
|
282
|
268
|
245
|
219
|
|
| Goodwill |
3
|
3
|
2
|
2
|
14
|
74
|
74
|
72
|
72
|
72
|
|
| Long-Term Investments |
210
|
218
|
300
|
269
|
288
|
475
|
431
|
344
|
289
|
329
|
|
| Other Long-Term Assets |
230
|
250
|
235
|
276
|
266
|
235
|
239
|
215
|
262
|
266
|
|
| Other Assets |
3
|
3
|
2
|
2
|
14
|
74
|
74
|
72
|
72
|
72
|
|
| Total Assets |
11 362
N/A
|
12 595
+11%
|
13 962
+11%
|
16 576
+19%
|
19 555
+18%
|
21 966
+12%
|
23 410
+7%
|
25 886
+11%
|
31 651
+22%
|
28 410
-10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 493
|
4 045
|
4 538
|
4 269
|
4 102
|
4 705
|
4 861
|
5 503
|
7 186
|
6 909
|
|
| Accrued Liabilities |
185
|
192
|
164
|
198
|
246
|
271
|
315
|
389
|
427
|
379
|
|
| Short-Term Debt |
4 671
|
4 644
|
5 407
|
6 899
|
8 626
|
9 574
|
10 111
|
8 962
|
8 409
|
7 044
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
1
|
1
|
78
|
1 480
|
2 299
|
|
| Other Current Liabilities |
327
|
822
|
608
|
1 646
|
2 165
|
2 571
|
1 915
|
2 593
|
4 782
|
1 934
|
|
| Total Current Liabilities |
8 676
|
9 703
|
10 717
|
13 011
|
15 143
|
17 122
|
17 203
|
17 525
|
22 284
|
18 566
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
1 029
|
2 753
|
2 325
|
2 237
|
|
| Deferred Income Tax |
61
|
35
|
26
|
26
|
34
|
95
|
92
|
70
|
54
|
55
|
|
| Minority Interest |
296
|
385
|
443
|
479
|
440
|
506
|
563
|
627
|
695
|
820
|
|
| Other Liabilities |
188
|
171
|
150
|
255
|
269
|
225
|
265
|
305
|
293
|
297
|
|
| Total Liabilities |
9 221
N/A
|
10 294
+12%
|
11 336
+10%
|
13 771
+21%
|
15 886
+15%
|
17 952
+13%
|
19 152
+7%
|
21 279
+11%
|
25 651
+21%
|
21 975
-14%
|
|
| Equity | |||||||||||
| Common Stock |
897
|
897
|
897
|
897
|
1 042
|
1 042
|
1 042
|
1 042
|
1 310
|
1 310
|
|
| Retained Earnings |
159
|
316
|
478
|
693
|
863
|
1 113
|
1 388
|
1 778
|
2 217
|
2 611
|
|
| Additional Paid In Capital |
1 084
|
1 085
|
1 172
|
1 136
|
1 661
|
1 662
|
1 652
|
1 652
|
2 429
|
2 460
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
90
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
36
|
|
| Other Equity |
1
|
2
|
79
|
79
|
103
|
198
|
177
|
135
|
0
|
0
|
|
| Total Equity |
2 141
N/A
|
2 301
+7%
|
2 626
+14%
|
2 805
+7%
|
3 669
+31%
|
4 014
+9%
|
4 258
+6%
|
4 606
+8%
|
6 000
+30%
|
6 435
+7%
|
|
| Total Liabilities & Equity |
11 362
N/A
|
12 595
+11%
|
13 962
+11%
|
16 576
+19%
|
19 555
+18%
|
21 966
+12%
|
23 410
+7%
|
25 886
+11%
|
31 651
+22%
|
28 410
-10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
897
|
897
|
897
|
897
|
1 042
|
1 042
|
1 042
|
1 042
|
1 292
|
1 292
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
